Vaneck Vectors Pharmaceutical etf shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $60 | 1 | 60.00 |
| 2023-09-30 | $50k | 626 | 79.83 |
| 2023-06-30 | $460k | 5.8k | 78.78 |
| 2022-12-31 | $387k | 5.0k | 77.74 |
| 2022-09-30 | $316k | 4.7k | 67.54 |
| 2022-06-30 | $360k | 4.7k | 76.84 |
| 2022-03-31 | $339k | 4.3k | 79.15 |
| 2021-12-31 | $361k | 4.7k | 77.22 |
| 2021-09-30 | $343k | 4.7k | 73.36 |
| 2021-06-30 | $343k | 4.7k | 73.36 |
| 2021-03-31 | $323k | 4.7k | 68.97 |
| 2020-12-31 | $284k | 4.7k | 60.00 |
| 2020-09-30 | $271k | 4.7k | 57.14 |
| 2020-06-30 | $292k | 4.8k | 60.61 |
| 2020-03-31 | $308k | 5.8k | 53.03 |
| 2019-12-31 | $476k | 7.9k | 60.61 |
| 2019-09-30 | $9.6M | 158k | 60.61 |
| 2019-06-30 | $493k | 8.1k | 60.61 |
| 2019-03-31 | $495k | 8.1k | 60.77 |
| 2018-12-31 | $410k | 7.5k | 54.80 |
| 2018-09-30 | $507k | 7.9k | 64.32 |
| 2018-06-30 | $470k | 8.0k | 59.03 |
| 2018-03-31 | $452k | 8.0k | 56.77 |
| 2017-12-31 | $467k | 7.9k | 59.25 |
| 2017-06-30 | $508k | 8.6k | 59.07 |
| 2017-03-31 | $484k | 8.8k | 55.00 |
| 2016-12-31 | $384k | 7.0k | 55.00 |
| 2016-09-30 | $374k | 6.8k | 55.00 |
| 2016-06-30 | $402k | 6.8k | 59.60 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf